<DOC>
	<DOCNO>NCT00229970</DOCNO>
	<brief_summary>This study evaluate efficacy safety MK0476 intravenous administration adult patient acute asthma .</brief_summary>
	<brief_title>MK0476 Study Adult Patients With Acute Asthma ( 0476-322 )</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Adult Patients With Acute Asthma Attacks Patient Has Any Known Or Suspected , Acute Or Chronic Cause For Their Pulmonary Symptoms Other Than Asthma ( E.G. , Copd , Chronic Heart Failure , Etc . ) Patient Has A Smoking History ( 20 Cigarettes Per Day ) Of More Than 15 Years Patient Has A Disease Of The Cardiovascular , Hepatic , Renal , Hematologic Systems , Or Other Severe Disease</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>